Surrozen, Inc.

NASDAQ:SRZN

Biotechnology

Healthcare
$31.74 -4.74%

-$1.14 today

Market cap
$237.33M
Beta
0.51
P/E (TTM)
-0.7
EPS (TTM)
-$31.29
52W Low $8.00High $35.00

Volume 0.31M

Average 0.11M

SRZN Other Non-current Liabilities

Long-term obligations not reported separately, such as lease or pension liabilities.

Surrozen, Inc.NASDAQ: SRZN

Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026

Other non-current liabilities rises 318.8% from a year ago

Other non-current liabilities stood at $384.44M at the end of Q1 FY2026, up 318.8% from a year earlier and up 41.8% from the prior quarter. Over 3 fiscal years it compounded at +840.5% a year.

Context

  • Other non-current liabilities amounted to 318.5% of total assets at the end of Q1 FY2026, up 238.5 pp from a year earlier.
  • Other non-current liabilities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +318.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$384.44M+41.8% QoQ
Last fiscal yearDec 2025
$271.21M+385.2% YoY
Year agoMar 2025
$91.8M+318.8% since
Other Non-current Liabilities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+318.8%——
1 year+385.2%——
3-year CAGR+840.5%——
5-year CAGR——
10-year CAGR——

Other Non-current Liabilities history

USD · from the balance sheet

Latest · FY2025
271.21M USD
Year-over-year change
+385.2%
4-year CAGR
+139.1%

Other Non-current Liabilities vs competitors

How SRZN compares with its peers on the latest reported figures

  • SRZN's Mar 2026 other non-current liabilities of $384.44M is the highest of the 8 companies compared; the peer median is $8K.
  • Its year-over-year change of +318.8% is the highest of 5, against a peer median of -57.7%.
  • Other non-current liabilities amounts to 318.5% of total assets for SRZN, versus a peer median of 0.0%.
SRZN Competitors Peer median
Other Non-current Liabilities for SRZN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SRZNSurrozen, Inc.Mar 2026$384.44M +318.8%+840.5%318.5%
IRDOpus Genetics, Inc.Mar 2026$77.35M +310.5%—115.8%
AGENAgenus Inc.Mar 2026$247K -99.9%-89.4%0.1%
SEERSeer, Inc.Mar 2026$26K -16.1%-70.8%0.0%
TILInstil Bio, Inc.Mar 2026$8K -99.2%-90.1%0.0%
IMMXImmix Biopharma, Inc.Mar 2026$0 ——0.0%
GLSIGreenwich LifeSciences, Inc.Mar 2026$0 ——0.0%
CGTXCognition Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding SRZN) $8K-57.7%-89.4%0.0%

Competitors are the stored peer set for SRZN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents33.09M24.69M36.04M34.57M89.25M
Short-term Investments68.76M51.15M000
Net Receivables01.98M2.15M2.54M208K
Inventory00000
Other Current Assets0756K580K671K2.11M
Total Current Assets105.19M81.31M41.13M38.93M91.56M
Property, Plant & Equipment (Net)9.38M6.9M3.86M8.36M6.43M
Goodwill00000
Intangible Assets00000
Long-term Investments21.66M0688K0688K
Tax Assets00000
Other Non-current Assets954K1.23M402K1.17M46K
Total Non-current Assets31.99M8.13M4.95M9.54M7.17M
Total Assets137.17M89.44M46.08M48.47M98.73M
Account Payables2.72M658K525K306K728K
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities589K581K292K191K289K
Total Current Liabilities13.57M9.73M7.15M7.32M9.93M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities8.3M326K115K55.89M271.21M
Total Non-current Liabilities13.9M3.7M997K62.53M276.56M
Total Liabilities27.47M13.43M8.15M69.85M286.49M
Common Stock4K0001K
Retained Earnings(142.65M)(178.65M)(221.7M)(285.26M)(527.29M)
Accumulated OCI(119K)(241K)000
Other Stockholders Equity00000
Minority Interest00000
Total Equity109.7M76M37.94M(21.38M)(187.76M)
Total Debt7.79M5.6M3.38M8.47M6.64M
Net Debt(25.3M)(19.09M)(32.66M)(26.1M)(82.61M)

Surrozen, Inc.

NASDAQ:SRZN

Intrinsic Alpha fair value

Locked

Current Price

$31.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.